APA (7th ed.) Citation

Li, X., Zeng, S., He, H., Zeng, X., Peng, L., & Chen, L. (2022). A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]. OncoTargets & Therapy, 15, 521. https://doi.org/10.2147/OTT.S372818

Chicago Style (17th ed.) Citation

Li, Xin-Long, Shan Zeng, Hai-Ping He, Xu Zeng, Li-Lei Peng, and Li-Gang Chen. "A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]." OncoTargets & Therapy 15 (2022): 521. https://doi.org/10.2147/OTT.S372818.

MLA (9th ed.) Citation

Li, Xin-Long, et al. "A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]." OncoTargets & Therapy, vol. 15, 2022, p. 521, https://doi.org/10.2147/OTT.S372818.